|
|
|
Insider
Information: |
Schoemaker Kathleen K |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
24 |
|
Direct
Shares |
8,715,548 |
|
Indirect Shares
|
3,038,103 |
|
|
Direct
Value |
$235,881,523 |
|
|
Indirect Value
|
$11,238,916 |
|
|
Total
Shares |
11,753,651 |
|
|
Total
Value |
$247,120,439 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-10 |
37,586 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2009-01-30 |
67,875 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
29,887 |
2008-07-16 |
62,513 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2014-02-12 |
2,972,678 |
2014-03-19 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
9,058 |
2011-12-22 |
50,643 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Alimera Sciences Inc |
ALIM |
10% Owner |
2014-01-16 |
3,590,931 |
2011-06-02 |
40,790 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2013-06-04 |
44,034 |
2011-11-21 |
51,013 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Tobira Therapeutics Inc |
TBRA |
10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Glaukos Corp |
GKOS |
10% Owner |
2015-06-30 |
2,068,960 |
2015-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
282 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2013-06-11 |
4 |
AS |
$5.00 |
$26,685 |
D/D |
(5,337) |
4,080,194 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-14 |
4 |
AS |
$5.36 |
$26,907 |
D/D |
(5,020) |
2,455,035 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-08 |
4 |
AS |
$5.32 |
$27,419 |
D/D |
(5,154) |
2,478,252 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-20 |
4 |
AS |
$5.22 |
$28,762 |
D/D |
(5,510) |
2,423,944 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-02-13 |
4 |
AS |
$5.00 |
$28,815 |
D/D |
(5,763) |
2,534,757 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-02-20 |
4 |
AS |
$5.01 |
$30,862 |
D/D |
(6,160) |
7,762,188 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-04-10 |
4 |
AS |
$6.72 |
$32,471 |
D/D |
(4,832) |
7,384,819 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2009-01-28 |
4 |
S |
$0.93 |
$34,131 |
I/I |
(36,700) |
72,738 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-12 |
4 |
AS |
$5.38 |
$34,141 |
D/D |
(6,346) |
2,467,788 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-01 |
4 |
AS |
$5.01 |
$38,251 |
D/D |
(7,635) |
2,509,130 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2013-03-06 |
4 |
S |
$24.51 |
$40,466 |
D/D |
(1,651) |
46,813 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-19 |
4 |
AS |
$5.19 |
$41,131 |
D/D |
(7,925) |
2,429,454 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-18 |
4 |
AS |
$5.16 |
$41,383 |
D/D |
(8,020) |
2,437,379 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-13 |
4 |
AS |
$5.40 |
$41,758 |
D/D |
(7,733) |
2,460,055 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-02-14 |
4 |
AS |
$5.01 |
$45,591 |
D/D |
(9,100) |
7,808,571 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-02-15 |
4 |
AS |
$5.00 |
$45,740 |
D/D |
(9,148) |
7,799,423 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-02-01 |
4 |
AS |
$4.85 |
$47,380 |
D/D |
(9,769) |
2,540,520 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-02-19 |
4 |
AS |
$5.02 |
$50,582 |
D/D |
(10,076) |
2,518,763 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-15 |
4 |
AS |
$5.28 |
$50,878 |
D/D |
(9,636) |
2,445,399 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2013-03-05 |
4 |
S |
$24.69 |
$52,639 |
D/D |
(2,132) |
48,464 |
0 |
- |
|
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2013-06-20 |
4 |
AS |
$5.01 |
$52,685 |
D/D |
(10,516) |
3,887,691 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-01-30 |
4 |
AS |
$5.00 |
$55,525 |
D/D |
(11,105) |
2,568,826 |
0 |
- |
|
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2011-06-02 |
4 |
S |
$8.04 |
$55,589 |
I/I |
(6,914) |
40,790 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2009-01-29 |
4 |
S |
$0.91 |
$57,330 |
I/I |
(63,000) |
71,302 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-03-06 |
4 |
AS |
$5.06 |
$59,915 |
D/D |
(11,841) |
7,698,480 |
0 |
- |
|
282 Records found
|
|
Page 7 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|